Debevoise & Plimpton advised LeapFrog Investment on the transaction. LeapFrog Investment (“LeapFrog”) announced the close of its fourth fund (“Fund IV”), with commitments and designated co-investments...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer is advising Sanofi, while Kirkland & Ellis and Debevoise & Plimpton are advising CD&R on the transaction. French drugmaker Sanofi and Clayton Dubilier...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton advised LGT Capital Partners on the deal. LGT Capital Partners announced the final close of its flagship secondaries fund, Crown Global Secondaries VI...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton and Carey Olsen advised FitzWalter Capital on the deal. FitzWalter Capital (“FitzWalter”) announced the final close of its second fund, FitzWalter Capital Partners...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton advised Mobilux 2 SAS (“BUT”) and Mobilux Confo SAS on the deal. Mobilux 2 SAS (“BUT”) and Mobilux Confo SAS (“Conforama”) and their...
You must be a Standard 1 Year member to access this content.
Kirkland and Ellis represented One Equity Partners, Ropes & Gray represented AlpInvest Partners, and Debevoise & Plimpton LLP has advised HarbourVest Partners in the transaction. One...
You must be a Standard 1 Year member to access this content.
